Use Of Takeda's Entyvio Fueled By Gastroenterologists Seeking Better Outcomes And Alternatives To AbbVie's Humira And Janssen's Remicade In The Treatment Of Crohn's Disease

ZUG Switzerland Sept. 23 2016 PRNewswire &160;In a market long dominated by AbbVie's Humira and Janssen's Remicade practice patterns are shifting and novel pipeline agents will introduce a new treatment paradigm in Crohn's Disease.In a recent study con...